Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
0.5786
+0.0084 (1.47%)
At close: Sep 25, 2026, 4:00 PM EDT
0.5755
-0.0031 (-0.54%)
After-hours: Sep 25, 2026, 6:22 PM EDT
Citius Pharmaceuticals Employees
Citius Pharmaceuticals had 23 employees as of September 30, 2025. The number of employees did not change compared to the previous year.
Employees
23
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$308,922
Profits / Employee
-$2,011,915
Market Cap
15.88M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 23 | 0 | - |
| Sep 30, 2024 | 23 | 1 | 4.55% |
| Sep 30, 2023 | 22 | 1 | 4.76% |
| Sep 30, 2022 | 21 | 6 | 40.00% |
| Sep 30, 2021 | 15 | 5 | 50.00% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Palatin Technologies | 29 |
| Cerenome | 28 |
| Passage Bio | 24 |
| BioCardia | 21 |
| Lantern Pharma | 16 |
| Kiora Pharmaceuticals | 13 |
| Actuate Therapeutics | 12 |
| Allarity Therapeutics | 8 |
CTXR News
- 11 days ago - Citius Pharmaceuticals Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 17 days ago - Citius Pharmaceuticals Transcript: Moody Capital Disruptive Growth & Life Science Conference - Transcripts
- 24 days ago - Citius Pharmaceuticals to Participate in September 2026 Investor Conferences - PRNewsWire
- 6 weeks ago - Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update - PRNewsWire
- 6 weeks ago - Citius Oncology, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update - PRNewsWire
- 6 weeks ago - Citius Pharmaceuticals Quarterly report: Q3 2026 - Filings
- 6 weeks ago - Citius Pharmaceuticals Earnings release: Q3 2026 - Filings
- 6 weeks ago - Citius Oncology Expands Board with Appointment of Independent Director Jonathan Peri - PRNewsWire